Cumberland Pharmaceuticals (CPIX) Payables: 2009-2025
Historic Payables for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $13.8 million.
- Cumberland Pharmaceuticals' Payables rose 14.72% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 6.66%. This contributed to the annual value of $13.9 million for FY2024, which is 0.88% down from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Payables stood at $13.8 million for Q3 2025, which was up 2.87% from $13.4 million recorded in Q2 2025.
- Cumberland Pharmaceuticals' Payables' 5-year high stood at $14.0 million during Q4 2023, with a 5-year trough of $9.0 million in Q2 2021.
- Over the past 3 years, Cumberland Pharmaceuticals' median Payables value was $13.1 million (recorded in 2024), while the average stood at $12.7 million.
- In the last 5 years, Cumberland Pharmaceuticals' Payables dropped by 28.03% in 2021 and then increased by 29.75% in 2023.
- Over the past 5 years, Cumberland Pharmaceuticals' Payables (Quarterly) stood at $9.6 million in 2021, then grew by 12.22% to $10.8 million in 2022, then rose by 29.75% to $14.0 million in 2023, then dropped by 0.88% to $13.9 million in 2024, then grew by 14.72% to $13.8 million in 2025.
- Its Payables was $13.8 million in Q3 2025, compared to $13.4 million in Q2 2025 and $13.9 million in Q1 2025.